Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

C O N M E D Cp (CNMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,429,842
  • Shares Outstanding, K 28,231
  • Annual Sales, $ 859,630 K
  • Annual Income, $ 40,850 K
  • 60-Month Beta 0.61
  • Price/Sales 2.77
  • Price/Cash Flow 19.05
  • Price/Book 3.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.53
  • Number of Estimates 4
  • High Estimate 0.54
  • Low Estimate 0.52
  • Prior Year 0.46
  • Growth Rate Est. (year over year) +15.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.15 +8.01%
on 06/03/19
87.61 -2.42%
on 06/20/19
+5.47 (+6.84%)
since 05/20/19
3-Month
76.91 +11.16%
on 04/18/19
87.61 -2.42%
on 06/20/19
+5.36 (+6.69%)
since 03/20/19
52-Week
56.90 +50.23%
on 12/26/18
87.61 -2.42%
on 06/20/19
+9.74 (+12.86%)
since 06/20/18

Most Recent Stories

More News
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)
DaVita Divests DMG to Optum, Boosts Kidney Care Services

The divestment of DMG boosts DaVita's (DVA) core Kidney Care business.

MASI : 146.42 (+0.56%)
XRAY : 57.74 (-0.02%)
CNMD : 85.56 (-0.59%)
DVA : 52.48 (+2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CNMD with:

Business Summary

CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology....

See More

Key Turning Points

2nd Resistance Point 87.42
1st Resistance Point 86.74
Last Price 85.56
1st Support Level 84.78
2nd Support Level 83.50

See More

52-Week High 87.61
Last Price 85.56
Fibonacci 61.8% 75.88
Fibonacci 50% 72.26
Fibonacci 38.2% 68.63
52-Week Low 56.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar